About Sri Sankaradeva Nethralaya
"In 1994, Sri Kanchi Sankara Health and Educational Foundation (SKSHEF) established Sri Sankaradeva Nethralaya in Guwahati. In 1995, the institution was dedicated to the nation by the then Prime Minister of India, Late P.V. Narsimha Rao Later, the President of India, Late K.R. Narayanan inaugurated Cornea Department and Department of Electro Physiology. In 1997, Structured Community Outreach programme was formally inaugurated by the then Governor of Assam, Late Loknath Mishra. Eye Bank was established in the year 1998.SSN has formally declared by the then Honourable Prime Minster of India Shri Manmohan Singh in 2004.The then Honourable President of India, Late A.P.J Abdul Kalam visited the institutions in 2006."
Clinical Trials at Sri Sankaradeva Nethralaya
During the past decade, Sri Sankaradeva Nethralaya conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Sri Sankaradeva Nethralaya
According to Clinical.Site data, the most researched conditions in "Sri Sankaradeva Nethralaya" are
"Panuveitis" (2 trials), "Uveitis" (2 trials), "Uveitis, Anterior" (2 trials), "Uveitis, Intermediate" (2 trials) and "Uveitis, Posterior" (2 trials). Many other conditions were trialed in "Sri Sankaradeva Nethralaya" in a lesser frequency.
Clinical Trials Intervention Types at Sri Sankaradeva Nethralaya
Most popular intervention types in "Sri Sankaradeva Nethralaya" are "Drug" (4 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Sham Procedure" (2 trials), "4 mg CLS-TA Suprachoriodal Injection" (1 trials), "4mg CLS-TA Suprachoriodal Injection" (1 trials), "DE-109 Intravitreal Injections" (1 trials) and "QPI-1007 Injection - 1.5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Sri Sankaradeva Nethralaya
The vast majority of trials in "Sri Sankaradeva Nethralaya" are
4 trials for "All" genders.
Clinical Trials Status at Sri Sankaradeva Nethralaya
Currently, there are NaN active trials in "Sri Sankaradeva Nethralaya".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Sri Sankaradeva Nethralaya,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Sri Sankaradeva Nethralaya, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".